Mark Andrew Sherman sold $963k of DLB
EVP, Gen. Counsel & Secretary at Dolby Laboratories, Inc.. 12,338 shares at an average of $78.08, traded Dec 17, 2024, filed Dec 18, 2024.
Score components
- +15RoleOfficer
- +24Trade size$963k at market
- +5Share of holdings soldSold 17% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-138158, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 16, 2024 | AGrant or award Class A Common Stock10b5-1 | +20,085 | $0.00 | $0 | 78,410 | Dec 18, 2024 |
| Dec 16, 2024 | MOption exercise Class A Common Stock10b5-1 | +5,192 | $0.00 | $0 | 83,602 | Dec 18, 2024 |
| Dec 16, 2024 | FTax withholding Class A Common Stock10b5-1 | -8,867 | $79.18 | $702k | 74,735 | Dec 18, 2024 |
| Dec 17, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -4,625 | $77.83 | $360k | 70,110 | Dec 18, 2024 |
| Dec 17, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -7,713 | $78.22 | $603k | 62,397 | Dec 18, 2024 |
| Dec 16, 2024 | AGrant or award Performance-Based Restricted Stock Unitderivative10b5-1 | +10,042 | $0.00 | $0 | 10,042 | Dec 18, 2024 |
| Dec 16, 2024 | AGrant or award Employee Stock Option (Right to Buy)derivative10b5-1 | +35,307 | $0.00 | $0 | 35,307 | Dec 18, 2024 |
| Dec 16, 2024 | MOption exercise Performance-Based Restricted Stock Unitderivative10b5-1 | -5,192 | $0.00 | $0 | 0 | Dec 18, 2024 |
Related signals
Other insiders at Dolby Laboratories, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $451k 7,667 shares | -4% | |
| 0Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $468k 7,667 shares | -6% | |
| 22Weak | Dolby Laboratories, Inc. | Mark Andrew Sherman EVP, Gen. Counsel & Secretary | $775k 11,600 shares | -14% | |
| 40Moderate | Dolby Laboratories, Inc. | Kevin J Yeaman President and CEO | $2.2M 33,517 shares | -25% | |
| 28Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $500k 7,273 shares | -6% | |
| 40Moderate | Dolby Laboratories, Inc. | Kevin J Yeaman President and CEO | $2.3M 34,367 shares | -26% | |
| 9Weak | Dolby Laboratories, Inc. | Mark Andrew Sherman EVP, Gen. Counsel & Secretary | $304k 4,500 shares | -7% | |
| 32Weak | Dolby Laboratories, Inc. | Tony A Prophet director | $224k 3,300 shares | -27% | |
| 35Weak | Dolby Laboratories, Inc. | Kevin J Yeaman President and CEO | $2.5M 36,699 shares | -24% | |
| 46Moderate | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $408k 6,164 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.